• Featured Product
  • KD/KO Validated

TRAIL/CD253 Polyklonaler Antikörper

TRAIL/CD253 Polyklonal Antikörper für WB, IHC, IF/ICC, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human

Anwendung

WB, IHC, IF/ICC, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 27064-1-PBS

Synonyme

TNFSF10, TRAIL, Apo-2 ligand, CD253, Protein TRAIL



Geprüfte Anwendungen

Produktinformation

27064-1-PBS bindet in WB, IHC, IF/ICC, ELISA TRAIL/CD253 und zeigt Reaktivität mit human

Getestete Reaktivität human
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen TRAIL/CD253 fusion protein Ag25746
Vollständiger Name tumor necrosis factor (ligand) superfamily, member 10
Berechnetes Molekulargewicht 281 aa, 33 kDa
Beobachtetes Molekulargewicht 33 kDa, 20 kDa
GenBank-ZugangsnummerBC032722
Gene symbol TRAIL
Gene ID (NCBI) 8743
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS only
LagerungsbedingungenStore at -80°C. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

TRAIL, also known as CD253 or TNFSF10 (tumor necrosis factor superfamily member 10), is a typical death ligand expressed on natural killer cells and cytotoxic T lymphocytes. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells although it is expressed at a significant level in most normal tissues. TRAIL induces apoptotic cell death in cancer by binding to its functional death receptors, death receptor (DR) 4 (TNFRSF10A/TRAIL-R1) and DR5 (TNFRSF10B/TRAIL-R2) to activate the extrinsic apoptosis pathway. TRAIL also activates c-Jun N-terminal kinase (MAPK8/JNK) and the transcription factor nuclear factor-κB (NFκB). The binding of this protein to its receptors has been shown to trigger the activation of MAPK8/JNK, caspase 8, and caspase 3.